Fundraising FoxMytide Therapeutics
Boston, US · Founded 2017 · Delaware corporation · 3 known investors
Find your way into Mytide Therapeutics
Sign up to see every warm intro you have to Mytide Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Mytide Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Mytide Therapeutics was founded in 2017 by Dale Thomas.
Investors · 3
__Twitter.png)
UNCOMMON DENOMINATORreportedNew York
How we know: funding news · alloytx.com · Not right? Tell us
Also in the syndicate · 1
Alloy Therapeuticslead
Reported raises · per SEC filings
Form D private placements$8.2M disclosed across 2 rounds · 2021–2022
▶$1.2MraisedJan 2023 · 9 investors · BiotechnologyRule 506(b)
▶$1.2MraisedJan 2023 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Errik AndersonDirector
- Jason NorrisExecutive Officer, Director, Promoter
- Dale ThomasExecutive Officer, Director, Promoter
- Offering amount
- $2.5M
- Amount sold
- $1.2M
- First sale
- Dec 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7.1MraisedJun 2022 · 23 investors · BiotechnologyRule 506(b)
▶$7.1MraisedJun 2022 · 23 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jason NorrisExecutive Officer, Director, Promoter
- Errik AndersonDirector
- Dale ThomasExecutive Officer, Director, Promoter
- Offering amount
- $7.1M
- Amount sold
- $7.1M
- First sale
- Dec 2021
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Science Foundation | Phase I | 2020 | $225K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- Who founded Mytide Therapeutics?
- Mytide Therapeutics was founded by Dale Thomas in 2017.
- Who are Mytide Therapeutics's investors?
- Mytide Therapeutics's investors include Gaingels, UNCOMMON DENOMINATOR.
- How much funding has Mytide Therapeutics raised?
- Mytide Therapeutics has disclosed $8.2M raised across 2 rounds.
- Where is Mytide Therapeutics headquartered?
- Mytide Therapeutics is headquartered in Boston, US.